Koninklijke Philips (PHG) EBT Margin Growth (3y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -305.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -9.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -222.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 923.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -480.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2,114.00 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1,391.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -176.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 329.00 |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | -122.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,114.00 |
| Dec 31, 2025 | 4,107.00 |
| Sep 30, 2025 | 5,697.00 |
| Jun 30, 2025 | 1,622.00 |
| Mar 31, 2025 | 813.00 |
| Dec 31, 2024 | -43.00 |
| Sep 30, 2024 | -278.00 |
| Jun 30, 2024 | 1,409.00 |
| Mar 31, 2024 | -2,030.00 |
| Dec 31, 2023 | -2,250.00 |
| Sep 30, 2023 | -1,017.00 |
| Jun 30, 2023 | -309.00 |
| Mar 31, 2023 | -1,589.00 |
| Dec 31, 2022 | -2,890.00 |
| Sep 30, 2022 | -5,855.00 |
| Jun 30, 2022 | -1,321.00 |
| Mar 31, 2022 | -1,130.00 |
| Dec 31, 2021 | -340.00 |
| Sep 30, 2021 | -997.00 |
| Jun 30, 2021 | -519.00 |
| Mar 31, 2021 | -440.00 |
| Dec 31, 2020 | 1,390.00 |
| Sep 30, 2020 | 776.00 |
| Jun 30, 2020 | 93.00 |
| Mar 31, 2020 | -511.00 |
| Dec 31, 2019 | -302.00 |
| Sep 30, 2019 | -336.74 Mn |
| Jun 30, 2019 | 451.00 |
| Mar 31, 2019 | 341.00 |
| Dec 31, 2018 | 352.00 |
| Sep 30, 2018 | 830.00 |
| Jun 30, 2018 | 0.00 |
| Mar 31, 2018 | 175.00 |
| Dec 31, 2017 | -461.00 |
| Mar 31, 2016 | -193.00 |
| Dec 31, 2015 | 121.00 |
| Sep 30, 2015 | 689.00 |
| Jun 30, 2015 | 237.00 |
| Mar 31, 2015 | -366.00 |
| Dec 31, 2014 | 1,227.00 |
| Mar 31, 2013 | -203.00 |
| Dec 31, 2012 | -521.00 |